GET MORE FROM MEDICINES.
RxAnte delivers analytics-powered solutions and clinical services that enable health plans, care providers, and pharmaceutical manufacturers to realize more value from medicines.
-
Our mission is to improve how medicines are prescribed, taken, and paid for. We do things like:
Help health plans improve Medicare Part D and HEDIS quality measures and avoid medical costs related to medication non-adherence.
Enable care providers to better understand and address barriers to their patients’ medication use.
Inform meaningful, evidence-driven discussions with pharmaceutical manufacturers and health plans about drug performance and contracting.
-
The no-obligation RxAnte Adherence Strategy Report is how top-performing Part D plans design their adherence programs.
Highly accurate performance forecasting. Know where you’ll land on the triple-weighted measures this year.
Program simulations. Learn how many interventions are needed to achieve your adherence goals.
Strategic advisory services. Our experts guide your program strategy.
-
Health Plans: Empower your Provider Networks
Deploy our workflow solution in the physician’s office to drive medication adherence and improve health outcomes. Read our case study to learn how one health plan incentivizes physicians to use RxEffect® and achieved up to a 7.8% increase in adherence.
The Results
Below are a few ways we measure medication performance improvement for our clients:
of Medicare Part D contract measures managed by RxAnte improve year-over-year
in annual savings opportunities identified for a health plan deploying our medical cost savings solution.
adherence improvement among plan members reached using our RxEffect® medication adherence workflow solution.
For Health Plans
Deploy our analytics-powered solutions to improve clinical quality, achieve medical cost savings, and better realize the value of medicines on your member populations.
Tell Me More
For Providers
Drive improvements in shared risk arrangements using our predictive analytics and direct-to-patient interventions to ensure patients’ adherence to their medicines.
Tell Me MoreFor Pharmaceutical Manufacturers
Demonstrate the value of drugs on real-world populations and engage in value-based contracts using our evidence-driven approach and transparent performance measurement analytics.
Tell Me More
Resources & Blog
More Resources
Value in Medication Adherence: Where Costs and Quality Intersect for MAPD Plans
Blog Post
For Medicare Advantage plans, value-based care is a double-edged sword. It can make it easier to grasp the importance of members’ needs. But it can create heightened sensitivity to the pressures of quality measures. We find that it helps to take a step back when looking at costs and quality.
Health Plans & Cut Points – Getting Ahead
Blog Post
Each year, cut points are announced in the fall and Medicare Advantage Part D (MAPD) plans anxiously anticipate their impact on Star Ratings. We interviewed our vice president of client services, Kerri Petrin, to find out what tips, tricks, and advice she gives to health plans in times like these.
Analyzing vs. Predicting – MAPD Plans Need Both for Better Star Ratings
Blog Post
Although there is some value in using trends from previous years to inform strategy, it misses the mark when it comes to improving adherence rates. To help plans inform planning and drive improvement, we take a closer look at comparing retrospective vs. prospective strategies.
Request More Info
Think RxAnte might be right for your organization? Let’s get in touch.
Let's Get Started